Related Experiment Video
Updated: Jun 17, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Simocyclinone D8 turns on against Gram-negative bacteria in a clinical setting
Sara N Richter1, Ilaria Frasson, Manlio Palumbo
1Department of Histology, Microbiology and Medical Biotechnologies, University of Padova, via Gabelli 63, 35121 Padova, Italy. sara.richter@unipd.it
Abstract:
Simocyclinone D8 (SD8) is known to affect Gram-positive bacteria only. By testing SD8 against several clinical isolates, we showed that SD8 resulted very active against Gram-negative bacteria from clinical specimens, while it was shown inactive against laboratory strains. The activity against the former was in part due to enhanced drug entry. In addition, SD8 appears to share chromosome- and plasmid-mediated resistance mechanisms with fluoroquinolones.
More Related Videos
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Antibiotic Selection
Clinical Significance of Antibiotic Resistance
Antimicrobial Effectiveness
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis

